WWW.JNEUROSCI.ORG
-
The Journal of Neuroscience
 QUICK SEARCH:   [advanced]


     
-


HOME
  |  
SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

The Journal of Neuroscience, October 27, 2004, 24(43):9553-9560; doi:10.1523/JNEUROSCI.1558-04.2004

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental data
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (22)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jenkins, B. G.
Right arrow Articles by Isacson, O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jenkins, B. G.
Right arrow Articles by Isacson, O.

 Previous Article  |  Next Article 

Neurobiology of Disease
Mapping Dopamine Function in Primates Using Pharmacologic Magnetic Resonance Imaging

Bruce G. Jenkins,1 Rosario Sanchez-Pernaute,3 Anna-Liisa Brownell,2 Yin-Ching Iris Chen,1,2 and Ole Isacson3

1Massachusetts General Hospital (MGH) Nuclear Magnetic Resonance Center, Athinoula A. Martinos Center for Biomedical Imaging and 2MGH Positron Emission Tomography Center, Massachusetts General Hospital, Boston, Massachusetts 02129, and 3Neuroregeneration Laboratory, McLean Hospital, Belmont, Massachusetts 02478

Dopamine (DA) receptors play a central role in such diverse pathologies as Parkinson's disease, schizophrenia, and drug abuse. We used an amphetamine challenge combined with pharmacologic magnetic resonance imaging (phMRI) to map DA-associated circuitry in nonhuman primates with high sensitivity and spatial resolution. Seven control cynomolgous monkeys and 10 MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine)-treated parkinsonian primates were studied longitudinally using both positron emission tomography (PET) and phMRI. Amphetamine challenge (2.5 mg/kg, i.v.) in control monkeys increased relative cerebral blood volume (rCBV) in a number of brain regions not described previously, such as parafascicular thalamus, precentral gyrus, and dentate nucleus of the cerebellum. With the high spatial resolution, we were also able to readily identify changes in rCBV in the anterior cingulate, substantia nigra, ventral tegmental area, caudate (tail and head), putamen, and nucleus accumbens. Amphetamine induced decreases in rCBV in occipital and posterior parietal cortices. Parkinsonian primates had a prominent loss of response to amphetamine, with relative sparing of the nucleus accumbens and parafascicular thalamus. There was a significant correlation between rCBV loss in the substantia nigra and both PET imaging of dopamine transporters and behavioral measures. Monkeys with partial lesions as defined by 2{beta}-carbomethoxy-3{beta}-(4-fluorophenyl) tropane binding to dopamine transporters showed recruitment of premotor and motor cortex after amphetamine stimulus similar to what has been noted in Parkinson's patients during motor tasks. These data indicate that phMRI is a powerful tool for assessment of dynamic changes associated with normal and dysfunctional DA brain circuitry in primates.

Key words: amphetamine; dopamine; MRI; macaque; Parkinson's disease; PET


Received April 23, 2004; revised September 3, 2004; accepted September 7, 2004.




This article has been cited by other articles:


Home page
NeuroscientistHome page
P. K. Liu, J. B. Mandeville, Guangping Dai, B. G. Jenkins, Y. R. Kim, and C. H. Liu
Transcription MRI: A New View of the Living Brain
Neuroscientist, October 1, 2008; 14(5): 503 - 520.
[Abstract] [PDF]


Home page
JNMHome page
D. Pellegrino, F. Cicchetti, X. Wang, A. Zhu, M. Yu, M. Saint-Pierre, and A.-L. Brownell
Modulation of Dopaminergic and Glutamatergic Brain Function: PET Studies on Parkinsonian Rats
J. Nucl. Med., July 1, 2007; 48(7): 1147 - 1153.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
H. Lu, Z.-X. Xi, L. Gitajn, W. Rea, Y. Yang, and E. A. Stein
Cocaine-induced brain activation detected by dynamic manganese-enhanced magnetic resonance imaging (MEMRI)
PNAS, February 13, 2007; 104(7): 2489 - 2494.
[Abstract] [Full Text] [PDF]



-
-

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help

-
Copyright 2009 by Society for Neuroscience ONLINE ISSN: 1529-2401
-